From March to December 2020, more than 16,500 deaths occurred in cancer patients with complications of COVID-19, according to a research letter published online Sept. 29 in JAMA Oncology.
Sep 30, 2022
0
4
A research team led by Matthias Preusser from MedUni Vienna's Division of Oncology had already demonstrated that cancer patients benefit from a third vaccination to protect them against COVID. A recent study now also supports ...
Sep 23, 2022
0
42
Active surveillance may be a viable strategy for most diagnosed thyroid cancers, according to a study published online Sept. 15 in JAMA Oncology.
Sep 22, 2022
0
4
Using the wrong mathematical formula to assess heartbeat rhythms may lead oncologists to inappropriately stop life-saving chemotherapy, according to research findings from UNC Lineberger Comprehensive Cancer Center scientists. ...
Sep 22, 2022
0
16
In a recent study published in JAMA Oncology, investigators from the University of Bergen, in collaboration with the Women's Health Initiative (WHI) study in the U.S., reported epigenetic gene silencing in normal tissue to ...
Sep 20, 2022
0
31
The overall incidence of cutaneous T-cell lymphoma (CTCL) increased in the United States from 2000 to 2018, according to a research letter published online Sept. 1 in JAMA Oncology.
Sep 13, 2022
0
7
Cell-based immunotherapy called CAR-T cell therapy has revolutionized the treatment of several cancers. The treatment uses genetically modified T cells to target and attack certain types of leukemia and lymphoma. While it ...
Sep 1, 2022
0
44
Women with a breast cancer diagnosis undergoing procedures for fertility preservation are not at increased risk of recurrence of the disease or disease-specific mortality. This has been shown in a study by Karolinska Institutet ...
Aug 25, 2022
0
16
The repercussions of overturning Roe v. Wade—and the failure of the Supreme Court to provide any guidance on exceptions related to the life and health of the mother—are potentially catastrophic for a subset of women who ...
Aug 15, 2022
0
61
Prostate-specific antigen (PSA) screening is associated with decreased risk of prostate cancer-specific mortality (PCSM) among both Black and White men, according to a study published online Aug. 4 in JAMA Oncology.
Aug 10, 2022
0
2
